Heterobicyclic compounds useful as p38 kinase inhibiting agents

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 471/04 (2006.01) A61K 31/4375 (2006.01) A61K 31/5025 (2006.01) A61P 19/00 (2006.01) A61P 29/00 (2006.01)

Patent

CA 2618614

Compounds described by the chemical formula (I) or pharmaceutically acceptable salts thereof: (I) are inhibitors of p38 and are useful in the treatment of inflammation such as in the treatment of rheumatoid arthritis, rheumatoid spondylitis, osteoarthritis, gouty arthritis and other arthritic conditions; inflamed joints, eczema, psoriasis or other inflammatory skin conditions such as sunburn; inflammatory eye conditions including conjunctivitis; pyresis, pain and other conditions associated with inflammation.

La présente invention se rapporte aux composés décrits par la formule chimique (I) ou aux sels pharmaceutiquement acceptables de celle-ci : (I) sont les inhibiteurs de p38 et sont utiles dans le traitement de l~inflammation comme dans le traitement de la polyarthrite rhumatoïde, la spondylarthrite ankylosante, l~arthrite goutteuse et les autres pathologies cliniques arthritiques ; les inflammations articulaires, l~eczéma, le psoriasis ou d~autres pathologies cliniques inflammatoires de la peau tels que l~érythème solaire ; les pathologies cliniques inflammatoires des yeux notamment la conjonctivite ; le pyrésis, la douleur et autres pathologies cliniques associées à l~inflammation.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Heterobicyclic compounds useful as p38 kinase inhibiting agents does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Heterobicyclic compounds useful as p38 kinase inhibiting agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterobicyclic compounds useful as p38 kinase inhibiting agents will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1469545

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.